- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Lumisys CR unit gets FDA nod
Film digitizer and PACS developer Lumisys received 510(k) clearance in May for ACR 2000, the company's new low-cost computed radiography reader (SCAN 5/13/98). The Sunnyvale, CA, company is currently field-testing the unit and plans to begin
Film digitizer and PACS developer Lumisys received 510(k) clearance in May for ACR 2000, the company's new low-cost computed radiography reader (SCAN 5/13/98). The Sunnyvale, CA, company is currently field-testing the unit and plans to begin showing it to OEM clients later this year, according to Lumisys president Philip Berman. Lumisys is planning a formal introduction of ACR 2000 at this year's Radiological Society of North America meeting, Berman said.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
